Literature DB >> 450

The selective eosinophil chemotactic activity of histamine.

R A Clark, J I Gallin, A P Kaplan.   

Abstract

Histamine diphosphate was shown to selectively attract human eosinophils from mixed granulocyte populations when over 20% eosinophils were used in a modified Boyden chamber chemotactic assay system. This effect of histamine is abolished by incubation with diamine oxidase (histaminase) and was generated by decarboxylation of L-histidine. A linear dose dependent increase in eosinophil migration was observed between 3 X 10(-7) M and 1.25 X 10(-6) M, while higher concentrations of histamine inhibited the migration of eosinophils. The attractant activity of histamine was not inhibited by H-1 or H-2 receptor antagonists, however, the inhibition of migration observed at higher histamine concentrations was reversed by metiamine, an H-2 receptor antagonist. The effects of histamine upon eosinophil migration were demonstrable using three different assays: (a) counting cells that had traversed 5-mum pore, 12-mum thick polycarbonate filters, (b) counting cells that had migrated various distances into a 3-mum pore, 145-mum cellulose nitrate filters, or (c) measuring the number of cells that had traversed an upper polycarbonate filter and migrated into a lower cellulose nitrate filter using 15Cr-labeled cells. The ability of histamine to enhance eosinophil migration was shown to be dependent upon the presence of a concentration gradient; histamine did not cause a dose-dependent increase in random motility. Furthermore, preincubation of the eosinophils with histamine deactivate the cells to further stimulation by histamine or by C5a. It is concluded that in low doses histamine is a chemoattractant for human eosinophils, while in higher doses histamine inhibits eosinophil migration. These observations may relate to the influx and localization of eosinophils in immediate hypersensitivity reactions.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 450      PMCID: PMC2190076          DOI: 10.1084/jem.142.6.1462

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Intracellular distribution of histamine.

Authors:  I MOTA; W T BERALDO; A G FERRI; L C JUNQUEIRA
Journal:  Nature       Date:  1954-10-09       Impact factor: 49.962

2.  The presence of histamine in tissue mast cells.

Authors:  J F RILEY; G B WEST
Journal:  J Physiol       Date:  1953-06-29       Impact factor: 5.182

3.  The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli.

Authors:  E Schiffmann; H V Showell; B A Corcoran; P A Ward; E Smith; E L Becker
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

4.  Properties of a subpopulation of T cells bearing histamine receptors.

Authors:  M Plaut; L M Lichtenstein; C S Henney
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

5.  Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin.

Authors:  M ROCHA E SILVA; W T BERALDO; G ROSENFELD
Journal:  Am J Physiol       Date:  1949-02

6.  Identification of basophil granulocytes as a site of allergic histamine release.

Authors:  T Ishizaka; R De Bernardo; H Tomioka; L M Lichtenstein; K Ishizaka
Journal:  J Immunol       Date:  1972-04       Impact factor: 5.422

7.  Eosinophilia. 3. The anaphylactic release from isolated human basophils of a substance that selectively attracts eosinophils.

Authors:  W E Parish
Journal:  Clin Allergy       Date:  1972-12

8.  The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung.

Authors:  A B Kay; K F Austen
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

9.  N-formylmethionyl peptides as chemoattractants for leucocytes.

Authors:  E Schiffmann; B A Corcoran; S M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

10.  An eosinophil leukocyte chemotactic factor of anaphylaxis.

Authors:  A B Kay; D J Stechschulte; K F Austen
Journal:  J Exp Med       Date:  1971-03-01       Impact factor: 14.307

View more
  63 in total

Review 1.  Histamine H4 antagonism: a therapy for chronic allergy?

Authors:  Bruce L Daugherty
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

2.  Eosinophilopoietin. A circulating low molecular weight peptide-like substance which stimulates the production of eosinophils in mice.

Authors:  A A Mahmoud; M K Stone; R W Kellermeyer
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

Review 3.  Molecular and biochemical pharmacology of the histamine H4 receptor.

Authors:  Rob Leurs; Paul L Chazot; Fiona C Shenton; Herman D Lim; Iwan J P de Esch
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

Review 4.  The role of histamine H4 receptor in immune and inflammatory disorders.

Authors:  E Zampeli; E Tiligada
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

5.  Histamine receptors on guinea-pig alveolar macrophages: chemical specificity and the effects of H1- and H2-receptor agonists and antagonists.

Authors:  P Diaz; D G Jones; A B Kay
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

6.  Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E2 in healthy volunteers: a double blind investigation.

Authors:  D G Sciberras; M M Goldenberg; J A Bolognese; I James; N S Baber
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

7.  Influence of histamine receptor antagonists on the dynamics of the cutaneous hypersensitivity reaction in patients infected with schistosoma haematobium.

Authors:  J R Snyman; D K Sommers; M D Gregorowski
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Role of secretory events in modulating human neutrophil chemotaxis.

Authors:  J I Gallin; D G Wright; E Schiffmann
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

9.  Effects of levamisole on normal and abnormal leukocyte locomotion.

Authors:  D G Wright; C H Kirkpatrick; J I Gallin
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

10.  Functional studies on human peritoneal eosinophils.

Authors:  S J Klebanoff; D T Durack; H Rosen; R A Clark
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.